Sorting out drug-eluting stents

The Lancet

Volumn 375, Issue 9720, 2010, Pages 1060-1062

  Webster, Mark WI ^a   Ormiston, John A ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ARTICLE; CLINICAL TRIAL; CORONARY STENT; DRUG ELUTING STENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; PRIORITY JOURNAL;

EID: 77950296974     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60402-3     Document Type: Note

References (14)

1. Rasmussen K., Maeng M., Kaltoft A., et al., on behalf of the SORT OUT III study group. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled trial. Lancet (2010) 10:1016/S0140-6736(10)60208-5 published online March 15.
2. Park SJ. Comparison of the efficacy and safety of zotarolimus-eluting stent versus sirolimus-eluting stent and paclitaxel-eluting stent for coronary lesions: the ZEST trial. Congress of the American College of Cardiology; Orlando, FL, USA; March 29, 2009.
3. Leon M.B., Mauri L., Popma J.J., et al., ENDEAVOR IV Investigators. A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions: 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol 55 (2010) 543-554
4. Leon M.B., Kandzari D.E., Eisenstein E.L., et al., ENDEAVOR IV Investigators. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (randomized, controlled trial of the Medtronic Endeavor drug [ABT-578] eluting coronary stent system versus the Taxus paclitaxel-eluting coronary stent system in de novo native coronary artery lesions). JACC Cardiovasc Interv 2 (2009) 1208-1218
5. Schömig A., Dibra A., Windecker S., et al. A meta-analysis of 16 randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in patients with coronary disease. J Am Coll Cardiol 50 (2007) 1373-1380
6. Lee S.W., Park S.W., Kim Y.H., et al. A randomized comparison of sirolimus-versus paclitaxel-eluting stent implantation in patients with diabetes mellitus. J Am Coll Cardiol 52 (2008) 727-733
7. Kedhi E., Joesoef K.S., McFadden E., et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 375 (2010) 201-209
8. Morice M.C., Colombo A., Meier B., et al., for the REALITY Trial Investigators. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
9. Galløe A.M., Thuesen L., Kelbæk H., et al., for the SORT OUT II Investigators. Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA 299 (2008) 409-416
10. Kandzari D.E., Leon M.B., Popma J.J., et al., ENDEAVOR III Investigators. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 2440-2447
11. Cook S., Ladich E., Nakazawa G., et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 120 (2009) 391-399
12. Camenzind E., Wijns W., Mauri L., et al., for the PROTECT Steering Committee and Investigators. Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation. Am Heart J 158 (2009) 902-909 .e5
13. Cook S., Wenaweser P., Togni M., et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
14. Meredith I.T., Worthley S., Whitbourn R., et al., RESOLUTE Investigators. Clinical and angiographic results with the next-generation Resolute stent system: a prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv 10 (2009) 977-985